AMBRISENTAN vs AMIFAMPRIDINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
AMBRISENTAN vs AMIFAMPRIDINE: Safety Overview
| Metric | AMBRISENTAN | AMIFAMPRIDINE |
|---|---|---|
| Total FAERS Reports | 86,197 | 2,424 |
| Deaths Reported | 10,291 | 203 |
| Death Rate | 11.9% | 8.4% |
| Hospitalizations | 32,910 | 680 |
| Average Patient Age | 59.5 yrs | 62.5 yrs |
| % Female Patients | 76.1% | 62.6% |
| FDA Approval Date | Apr 10, 2019 | Nov 28, 2018 |
| Manufacturer | Sigmapharm Laboratories, LLC | Catalyst Pharmaceuticals, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |